Evidence map›Paper›PMID 41592126›Full record

ArticlePLoS neglected tropical diseases2026

Direct sequencing of Leishmania donovani from patients in Garissa County, Northern Kenya, reveals a newly emerging intra-specific hybrid genotype.

Vane Kwamboka Omwenga, Gathii Kimita, Damaris Matoke-Muhia, Cyrus Ayieko, Clement Masakhwe, Mohamed Hussein Ibrahim, Senne Heeren, Jean-Claude Dujardin, Pieter Monsieurs, Malgorzata Anna Domagalska and 1 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vane Kwamboka OmwengaKenya Medical Research Institute/Walter Reed Army Institute of Research - Africa, Basic Science Laboratory, Kisumu, Kenya.
Gathii KimitaKenya Medical Research Institute/Walter Reed Army Institute of Research - Africa, Basic Science Laboratory, Kisumu, Kenya.
Damaris Matoke-MuhiaKenya Medical Research Institute, Centre for Biotechnology Research Development (CBRD), Nairobi, Kenya.
Cyrus AyiekoDepartment of Zoology, Maseno University School of Biological and Physical Science, Kisumu, Kenya.
Clement MasakhweKenya Medical Research Institute/Walter Reed Army Institute of Research - Africa, Basic Science Laboratory, Kisumu, Kenya.
Mohamed Hussein IbrahimDepartment of Health, Garissa County Referral Hospital, Garissa County Kenya.
Senne HeerenInstitute of Tropical Medicine, Molecular Parasitology Unit, Antwerp, Belgium.
Jean-Claude DujardinInstitute of Tropical Medicine, Molecular Parasitology Unit, Antwerp, Belgium.
Pieter MonsieursInstitute of Tropical Medicine, Trypanosoma Unit, Antwerp, Belgium.
Malgorzata Anna DomagalskaInstitute of Tropical Medicine, Experimental Parasitology Unit, Antwerp, Belgium.
John WaitumbiKenya Medical Research Institute/Walter Reed Army Institute of Research - Africa, Basic Science Laboratory, Kisumu, Kenya.ORCID https://orcid.org/0000-0003-2540-4397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLeishmaniasis is endemic in many countries, and in Kenya outbreaks of visceral leishmaniasis (VL) commonly occur in Garissa, Isiolo, Marsabit, Turkana, and Wajir. Despite the rising frequency of VL outbreaks, there is limited data on the genetic structure and epidemiology of Leishmania parasites from these regions. This study used molecular methods to characterize Leishmania parasites collected at Garissa County Referral Hospital during the 2019-2022 VL outbreak.

methods286 blood samples, collected from patients suspected of having VL at Garissa County Referral Hospital between 2019 and 2022 were used. Leishmania parasites were screened at genus level by a quantitative real-time PCR assay targeting the arginine permease gene AAP3 (AAP3-qRT-PCR). Species identification and targeted gene sequencing were made on Illumina MiSeq using PCR amplicons of Hsp70 gene and ITS regions. Whole genome sequencing (WGS) was performed directly on eight selected blood samples using a target enrichment method after which data was analyzed using phylogenomic tools.

resultsBy AAP3-qRT-PCR, 128/286 (45%) blood specimens were determined to have Leishmania parasites. We obtained 86 Hsp70 and 79 ITS sequences that phylogenetically clustered with the L. donovani species complex. By WGS, the eight selected samples had L. donovani s.s., and clustered in two separate groups: one similar to the previously reported L. donovani group 5 and the other constituted a new and intra-specific hybrid genetic variant not reported previously. In all the 8 Kenya samples, we found SNPs in genes previously shown to be involved in L. donovani resistance to Antimony, Amphotericin B and Miltefosine.

conclusionThis pilot study reveals the complex nature of Leishmania genetic structure in Kenya and sheds light on the genomic polymorphism of L. donovani in this region, which in turn, may explain the evolving threat of VL in the region. As caveat, the genomic signatures of drug resistance genes that were identified should be interpreted with caution until their functional implication is clarified in future phenotypic studies.

Indexed as

GenotypeLeishmania donovaniLeishmaniasis, VisceralDNA, ProtozoanHumansKenyaPhylogenySequence Analysis, DNAWhole Genome SequencingDNA, Protozoan

Identifiers

PMID41592126
PMCPMC12875589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.